OrganiGram Holdings Revenue vs. EBITDA
| OGI Stock | USD 1.44 0.03 2.04% |
Total Revenue | First Reported 2014-09-30 | Previous Quarter 37.6 M | Current Value 41.1 M | Quarterly Volatility 16.5 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.21 | 0.2165 |
|
|
For OrganiGram Holdings profitability analysis, we use financial ratios and fundamental drivers that measure the ability of OrganiGram Holdings to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well OrganiGram Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between OrganiGram Holdings's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of OrganiGram Holdings over time as well as its relative position and ranking within its peers.
OrganiGram |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.79) | Revenue Per Share 1.835 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.55) |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
OrganiGram Holdings EBITDA vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining OrganiGram Holdings's current stock value. Our valuation model uses many indicators to compare OrganiGram Holdings value to that of its competitors to determine the firm's financial worth. OrganiGram Holdings is regarded second in revenue category among its peers. It also is regarded second in ebitda category among its peers . As of now, OrganiGram Holdings' Total Revenue is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OrganiGram Holdings' earnings, one of the primary drivers of an investment's value.OrganiGram Revenue vs. Competition
OrganiGram Holdings is regarded second in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 763.23 Million. OrganiGram Holdings retains roughly 149.21 Million in revenue claiming about 20% of equities under Health Care industry.
OrganiGram EBITDA vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
OrganiGram Holdings |
| = | 149.21 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
OrganiGram Holdings |
| = | (25.37 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
OrganiGram EBITDA Comparison
OrganiGram Holdings is currently under evaluation in ebitda category among its peers.
OrganiGram Holdings Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in OrganiGram Holdings, profitability is also one of the essential criteria for including it into their portfolios because, without profit, OrganiGram Holdings will eventually generate negative long term returns. The profitability progress is the general direction of OrganiGram Holdings' change in net profit over the period of time. It can combine multiple indicators of OrganiGram Holdings, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 38.2 M | 40.1 M | |
| Operating Income | -43.9 M | -41.7 M | |
| Income Before Tax | -209.7 M | -199.2 M | |
| Net Loss | -206.5 M | -196.2 M | |
| Income Tax Expense | 4 M | 4.2 M | |
| Total Other Income Expense Net | -165.8 M | -157.5 M | |
| Net Loss | -12.9 M | -13.5 M | |
| Net Loss | -206.5 M | -196.2 M | |
| Net Interest Income | -386.1 K | -405.4 K | |
| Interest Income | 11.8 M | 12.4 M | |
| Change To Netincome | 200.8 M | 210.8 M | |
| Net Loss | (0.18) | (0.19) | |
| Income Quality | 2.54 | 2.66 | |
| Net Income Per E B T | 0.99 | 1.16 |
OrganiGram Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on OrganiGram Holdings. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of OrganiGram Holdings position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the OrganiGram Holdings' important profitability drivers and their relationship over time.
Use OrganiGram Holdings in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OrganiGram Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OrganiGram Holdings will appreciate offsetting losses from the drop in the long position's value.OrganiGram Holdings Pair Trading
OrganiGram Holdings Pair Trading Analysis
The ability to find closely correlated positions to OrganiGram Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OrganiGram Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OrganiGram Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OrganiGram Holdings to buy it.
The correlation of OrganiGram Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OrganiGram Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OrganiGram Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OrganiGram Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your OrganiGram Holdings position
In addition to having OrganiGram Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Macroaxis Index Thematic Idea Now
Macroaxis Index
An experimental equal-weighted index theme of selected equities generated based on Macroaxis rating and scoring system. The Macroaxis Index theme has 52 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Index Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
To fully project OrganiGram Holdings' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of OrganiGram Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include OrganiGram Holdings' income statement, its balance sheet, and the statement of cash flows.